首頁 > 市場調查報告書 > 醫療設備

體外診斷

藥物濫用檢測市場規模、佔有率、成長分析（按產品類型、應用、最終用戶和地區）- 產業預測，2025 年至 2032 年

市場調查報告書

商品編碼

1789252

藥物濫用檢測市場規模、佔有率、成長分析（按產品類型、應用、最終用戶和地區）- 產業預測，2025 年至 2032 年

Drugs Of Abuse Testing Market Size, Share, and Growth Analysis, By Product (Consumables, Equipment), By Sample Type (Saliva, Urine), By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年08月07日 | 出版商:

SkyQuest | 英文 181 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球藥物濫用檢測市場價值為 67 億美元，預計將從 2024 年的 68 億美元成長到 2032 年的 76.6 億美元，預測期內（2025-2032 年）的複合年成長率為 1.5%。

全球藥物濫用檢測市場正經歷顯著成長，這得益於人們越來越重視就業現場的醫療篩檢以及藥物濫用日益普遍。隨著人們對藥物濫用障礙的認知不斷提高以及對藥物相關死亡的日益擔憂，對可靠檢測方法的迫切需求進一步推動了這一趨勢。就地檢驗和快速檢測 (POCT) 等檢測技術創新日益增多，為路邊和職場篩檢提供了及時且準確的結果。此外，使用唾液、汗水和頭髮的非侵入性檢測方法由於其便利性和低污染風險而越來越受歡迎。然而，新興市場認知度低、設備成本高和法規嚴格等挑戰可能會阻礙市場擴張。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）

主要企業簡介

Quest Diagnostics Incorporated
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Quidel Corporation
Express Diagnostics International Inc.
Blue Origin
Thermo Fisher Scientific, Inc
Siemens Healthcare GmbH
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Laboratory Corporation of America Holdings
Clinical Reference Laboratory, Inc.
Cordant Health Solutions
Merck KGaA

結論和建議

簡介目錄

Product Code: SQMIG35J2146

Global Drugs Of Abuse Testing Market size was valued at USD 6.7 billion in 2023 and is poised to grow from USD 6.8 billion in 2024 to USD 7.66 billion by 2032, growing at a CAGR of 1.5% during the forecast period (2025-2032).

The global drugs of abuse testing market is experiencing significant growth driven by an increasing emphasis on employment medical screenings and a rising incidence of substance use. This trend is further fueled by heightened awareness of substance use disorders and the urgent need for reliable testing methods amid alarming rates of drug-related fatalities. Innovations in testing technology, such as point-of-care and rapid testing (POCT), are on the rise, offering timely and accurate results for roadside and workplace screenings. Additionally, non-invasive testing methods using saliva, sweat, and hair are gaining traction for their convenience and lower contamination risks. However, challenges like limited awareness in developing regions, high device costs, and stringent regulations may hinder market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drugs Of Abuse Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drugs Of Abuse Testing Market Segments Analysis

Global Drugs Of Abuse Testing Market is segmented by Product, Sample Type, Application, End User and region. Based on Product, the market is segmented into Consumables, Equipment, Rapid Testing Devices and Services. Based on Sample Type, the market is segmented into Saliva, Urine, Hair, Breath, Blood and Sweat. Based on Application, the market is segmented into Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing and Sports & Athletics Testing. Based on End User, the market is segmented into Hospital, Forensic Labs, Diagnostic Centres and Speciality Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drugs Of Abuse Testing Market

The Global Drugs of Abuse Testing market is primarily driven by advancements in technology that have led to the creation of more precise and reliable testing instruments. As living standards continue to improve, there is a growing emphasis on drug abuse testing among adults, which is being actively promoted by both governmental and private sectors. This initiative aims to address and mitigate issues related to drug misuse, contributing to the overall expansion of the market. The increasing awareness of the importance of drug testing, coupled with enhanced testing methodologies, plays a crucial role in fostering market growth.

Restraints in the Global Drugs Of Abuse Testing Market

The global drugs of abuse testing market faces significant challenges related to cost and affordability, which hinder its widespread adoption. Many smaller companies and healthcare providers find comprehensive testing programs prohibitively expensive, limiting growth opportunities within the industry. Additionally, the market grapples with issues surrounding adulteration and evasion tactics, as individuals often resort to methods such as using synthetic urine or masking agents to circumvent testing protocols. These practices undermine the efficacy of screening methods and pose further obstacles to maintaining the integrity and reliability of drug testing processes within the market.

Market Trends of the Global Drugs Of Abuse Testing Market

The Global Drugs Of Abuse Testing market is experiencing a significant shift towards non-invasive testing techniques, propelled by the growing demand for simplified, safe, and privacy-friendly collection methods. Sample types such as sweat, hair, and saliva are increasingly favored over traditional invasive procedures like blood or urine, as they offer enhanced convenience and reduced contamination risks. This trend is further amplified by the ability of non-invasive methods to provide longer detection windows, making them ideal for applications in roadside testing, rehabilitation centers, and workplace settings. As these technologies continue to advance, they are set to reshape the landscape of drugs of abuse testing.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Customer Buying Behavior Analysis

Global Drugs Of Abuse Testing Market Size by Product & CAGR (2025-2032)

Market Overview
Consumables
Equipment
Rapid Testing Devices
Services

Global Drugs Of Abuse Testing Market Size by Sample Type & CAGR (2025-2032)

Market Overview
Saliva
Urine
Hair
Breath
Blood
Sweat

Global Drugs Of Abuse Testing Market Size by Application & CAGR (2025-2032)

Market Overview
Medical Screening
Monitoring Pain Management
Forensic & Legal Information
Employment Drug Testing
Sports & Athletics Testing

Global Drugs Of Abuse Testing Market Size by End User & CAGR (2025-2032)

Market Overview
Hospital
Forensic Labs
Diagnostic Centres
Speciality Clinics

Global Drugs Of Abuse Testing Market Size & CAGR (2025-2032)

North America (Product, Sample Type, Application, End User)
- US
- Canada
Europe (Product, Sample Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Sample Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Sample Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Sample Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024

Key Company Profiles

Quest Diagnostics Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Express Diagnostics International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Blue Origin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthcare GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinical Reference Laboratory, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordant Health Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments